2019 Fellows Courses

TAVR Today: Focus on Safety with the Repositionable LOTUS Edge Valve and SENTINEL Cerebral Protection System

In this program, today’s thought leaders will share their perspectives on the past decade in TAVR, present a case example on the only FDA-approved completely repositionable valve, describe how to mitigate stroke in TAVR, and provide a glimpse into the future of Boston Scientific’s structural heart portfolio.
Perspectives on the Past Decade in TAVR
Steven J. Yakubov, M.D., MSCAI, OhioHealth Heart & Vascular Physicians, Columbus, OH
Stroke in TAVR: Incidence, Cost, and Protection
Kendra J. Grubb, M.D., Emory University, Atlanta, GA
Glimpse into the Future of BSC Structural Heart
James M. McCabe, MD, FSCAI, The University of Washington, Seattle, WA